BNP Paribas Financial Markets’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.5K Sell
12,627
-71,734
-85% -$258K ﹤0.01% 3480
2025
Q1
$252K Sell
84,361
-12,072
-13% -$36.1K ﹤0.01% 2767
2024
Q4
$323K Buy
+96,433
New +$323K ﹤0.01% 2763